Press Releases DermTech, Inc.

Equities

DMTK

US24984K1051

Delayed Nasdaq Other stock markets 07:20:45 13/05/2024 pm IST			5-day change	1st Jan Change
0.627 ^USD	+0.37%		+0.02%	-64.15%

22/04	North American Morning Briefing : Stock Futures -2-	DJ
19/04	Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DermTech : Accelaration/Increase of Financial Obligation - Form 8-K	11/05	PU
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan	19/04	BU
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	02/04	BU
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology	11/03	AQ
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology	08/03	BU
DermTech : 2023 Q4 Transcript	01/03	PU
DermTech Reports Fourth-Quarter 2023 Financial Results	01/03	BU
DermTech Announces Release Date for Fourth-quarter 2023 Financial Results	13/02	BU
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations	01/02	BU
DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test across All Skin Types	19/01	AQ
DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types	18/01	BU
DERMTECH SIMPLIFIES THE DERMTECH MELANOMA TEST BY DISCONTINUING THE OPTIONAL TERT ADD-ON ASSAY	17/01	AQ
DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay	16/01	BU
DERMTECH ANNOUNCES POSITIVE TOPLINE RESULTS FROM TRUST 2 STUDY EVALUATING THE DERMTECH MELANOMA TEST	09/01	AQ
DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)	08/01	BU
DERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	29/12	BU
DMTK DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action – DMTK	15/12	BU
DERMTECH ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	15/12	AQ
DMTK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action - DMTK	15/12	PR
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	15/12	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases DermTech, Inc.

Equities

DMTK

US24984K1051

Press Releases

Filters